Quality of life of patients with ADPKD - Toranomon PKD QOL study: Cross-sectional study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Suwabe, Tatsuya ^a   Ubara, Yoshifumi ^a   Mise, Koki ^a   Kawada, Masahiro ^a   Hamanoue, Satoshi ^a   Sumida, Keiichi ^a   Hayami, Noriko ^a   Hoshino, Junichi ^a   Hiramatsu, Rikako ^a   Yamanouchi, Masayuki ^a   Hasegawa, Eiko ^a   Sawa, Naoki ^a   Takaichi, Kenmei ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Dialysis; Polycystic kidney disease; Quality of life; Total liver and kidney volume

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ABDOMINAL DISTENSION; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANOREXIA; ARTICLE; ASCITES; CEREBROVASCULAR DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FEVER; HEALTH SURVEY; HEARTBURN; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HUMAN; JAPANESE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBSERVATIONAL STUDY; PAIN; QUALITY OF LIFE; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SCORING SYSTEM; SHORT FORM 36; SLEEP DISORDER;

EID: 84883088601     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-179     Document Type: Article

References (16)

1. Polycystic kidney disease re-evaluated: a population-based study. Davies F, Coles GA, Harper PS, Williams AJ, Evans C, Cochlin D, Q J Med 1991 79 290 477 485 1946928
2. Autosomal dominant polycystic kidney disease. Gabow PA, N Engl J Med 1993 329 5 332 342 10.1056/NEJM199307293290508 8321262 (Pubitemid 23210687)
3. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Ubara Y, Tagami T, Sawa N, Katori H, Yokota M, Takemoto F, Inoue S, Kuzuhara K, Hara S, Yamada A, Am J Kidney Dis 2002 39 3 571 579 10.1053/ajkd.2002.31407 11877576 (Pubitemid 34194633)
4. Intravascular embolization therapy in a patient with an enlarged polycystic liver. Ubara Y, Takei R, Hoshino J, Tagami T, Sawa N, Yokota M, Katori H, Takemoto F, Hara S, Takaichi K, Am J Kidney Dis 2004 43 4 733 738 10.1053/j.ajkd.2003.12.035 15042552 (Pubitemid 38401890)
5. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver. Ubara Y, TherApher Dial 2006 10 4 333 341 10.1111/j.1744-9987.2006.00386.x (Pubitemid 44154763)
6. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease. Takei R, Ubara Y, Hoshino J, Higa Y, Suwabe T, Sogawa Y, Nomura K, Nakanishi S, Sawa N, Katori H, Takemoto F, Hara S, Takaichi K, Am J Kidney Dis 2007 49 6 744 752 10.1053/j.ajkd.2007.03.018 17533017 (Pubitemid 46802936)
7. Psychological factors affecting end-stage renal disease. Levenson JL, Glocheski S, Psychosomatics 1991 32 4 382 389 10.1016/S0033-3182(91)72038-0 1961849
8. Pain management in polycystic kidney disease. Bajwa ZH, Gupta S, Warfield CA, Steinman TI, Kidney int 2001 60 5 1631 1644 10.1046/j.1523-1755.2001.00985. x 11703580 (Pubitemid 32999967)
9. «An evil heritage»: interview study of pain and autosomal dominant polycystic kidney disease. Heiwe S, Bjuke M, Pain Manag Nurs 2009 10 3 134 141 10.1016/j.pmn.2009.03.002 19706350
10. TEMPO 3:4 Trial investigators: tolvaptan in patients with autosomal dominant polycystic kidney disease. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, N Engl J Med 2012 367 25 2407 2418 10.1056/NEJMoa1205511 23121377
11. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis. Rizk D, Jurkovitz C, Veledar E, Bagby S, Baumgarten DA, Rahbari-Oskoui F, Steinman T, Chapman AB, Clin J Am Soc Nephrol 2009 4 3 560 566 10.2215/CJN.02410508 19261830
12. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K, J Clin Epidemiol 1998 51 11 1037 1044 10.1016/S0895-4356(98)00095-X 9817121 (Pubitemid 28527159)
13. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B, J Clin Epidemiol 1998 51 11 1045 1053 10.1016/S0895-4356(98)00096-1 9817122 (Pubitemid 28527160)
14. Fukuhara S, Suzukamo Y, Manual of SF-36v2 Japanese version Kyoto: Institute for Health Outcomes & Process Evaluation research 2004
15. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM, Lancet 1994 343 8901 824 827 10.1016/S0140-6736(94) 92026-5 7908078 (Pubitemid 24147512)
16. Current status of dialysis therapy and related clinical guidelines in Japan. Akizawa T, Japan Medical Association Journal 2010 53 3 185 187